Clinical and molecular genetics of the phosphodiesterases (PDEs)

MF Azevedo, FR Faucz, E Bimpaki, A Horvath… - Endocrine …, 2014 - academic.oup.com
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …

Neural mechanisms of sexual behavior in the male rat: emphasis on ejaculation-related circuits

JG Veening, LM Coolen - Pharmacology Biochemistry and Behavior, 2014 - Elsevier
Sexual behavior of the male rat can be described as a 'sequence': a series of behavioral
transitions eventually leading to a consummatory act: ejaculation. A 'funnel-model'is …

Sildenafil/Viagra in the treatment of premature ejaculation

P Krishnappa, E Fernandez-Pascual… - International journal of …, 2019 - nature.com
The arrival of Pfizer's blue pill Sildenafil in 1998 brought a great relief both to patient and
physician signalling the start of a great era of medical therapy in sexual medicine. Since …

Physiological and pharmacological aspects of the vas deferens—an update

DS Koslov, KE Andersson - Frontiers in pharmacology, 2013 - frontiersin.org
The vas deferens, a muscular conduit conveying spermatozoa from the epididymis to the
urethra, has been used as a model tissue for smooth muscle pharmacological and …

[HTML][HTML] Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management

A Kaltsas, F Dimitriadis, A Zachariou, N Sofikitis… - Cells, 2025 - mdpi.com
Phosphodiesterases, particularly the type 5 isoform (PDE5), have gained recognition as
pivotal regulators of male reproductive physiology, exerting significant influence on testicular …

The Effect of PDE5 inhibitors on the male reproductive tract

N Sofikitis, A Kaltsas, F Dimitriadis… - Current …, 2021 - benthamdirect.com
The therapeutic range of cyclic nucleotide phosphodiesterase 5 inhibitors (PDE5) inhibitors
is getting wider in the last years. This review study focuses on the potential employment of …

Phosphodiesterase inhibitors (PDE inhibitors) and male reproduction

EZ Drobnis, AK Nangia, EZ Drobnis… - Impacts of Medications on …, 2017 - Springer
The nonspecific PDE inhibitors, particularly the methylxanthines: caffeine, pentoxifylline
(PTX), and theophylline, are known to stimulate sperm motility in vitro and have been used …

PDE5 inhibitor treatment options for urologic and non-urologic indications: 2012 update

S Gur, P J. Kadowitz, E Can Serefoglu… - Current …, 2012 - benthamdirect.com
Phosphodiesterase (PDE) enzymes are widely distributed throughout the body, having
numerous effects and functions. The use of on demand PDE5 inhibitors (-Is) for the treatment …

Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human seminal vesicles

HE Rahardjo, S Ückert, MA Kuczyk… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aims The transient receptor potential cationic channel ankyrin 1
(TRPA1), a channel protein permeable to most divalent cations, has been suggested to play …

Seminal vesicles and diabetic neuropathy: ultrasound evaluation after prolonged treatment with a selective phosphodiesterase‐5 inhibitor

S La Vignera, RA Condorelli, E Vicari, F Lotti… - …, 2013 - Wiley Online Library
We have previously reported that infertile patients with diabetes mellitus (DM) have a
particular ultrasound features of the seminal vesicles (SV) characterized by higher fundus‐to …